International Law Office

Latest updates

Foo Joon Liang

Section 30 of CIPAA – road less travelled has now widened

Litigation - Malaysia
Gan Partnership

While most companies which have obtained an adjudication decision in their favour choose to apply for said decision to be enforced via Section 28 of the Construction Industry Payment and Adjudication Act (CIPAA), the less-travelled road of demanding payment for an adjudication decision via Section 30 of the CIPAA is proving to be another effective recourse for payment – as evidenced by a recent high court decision..

Daniel Maine

Trust company's £550,000 fine demonstrates importance of effective and consistent AML procedures

Private Client & Offshore Services - Jersey
Ogier

The Royal Court recently imposed a hefty £550,000 fine on a firm for failing to ensure that, in practice, its anti-money laundering (AML) policies and procedures were being applied effectively and consistently.

Bruce Bennett

Supreme Court: mere retention of property does not violate automatic stay

Insolvency & Restructuring - USA
Jones Day

In January 2021 the Supreme Court held that a creditor in possession of a debtor's property does not violate the automatic stay, specifically Section 362(a)(3) of the Bankruptcy Code, by retaining the property after the filing of a bankruptcy petition.

Diana Quaia

Section 232 steel and aluminium duties litigation shifts into high gear

International Trade - USA
Arent Fox LLP

It has been almost three years since the 25% duties on steel imports and the 10% duties on aluminium imports pursuant to Section 232 of the Trade Expansion Act 1962 were first imposed and legal challenges are proliferating and there is renewed legislative interest in Section 232 reform.

Francisco Venetucci

New regulation aims to combat spread of Asian and Japanese gypsy moths

Shipping & Transport - Argentina
Venetucci & Asociados

A new regulation has entered into force to combat the risk of Asian and Japanese gypsy moths being transported into Argentina.

Andrea Berenbaum

Federal Court of Appeal upholds Federal Court decision finding Shire's VYVANSE patent valid

Healthcare & Life Sciences - Canada
Smart & Biggar

The Federal Court of Appeal has dismissed Apotex's appeal of the Federal Court decision which held that the claims of Canadian Patent 2,527,646 were valid and prohibited the minister of health from issuing a notice of compliance to Apotex for its lisdexamfetamine product (Shire's VYVANSE) until the patent's expiry.

OnDemand

1

Corporate and commercial: trends and issues

Corporate & Commercial / Cyprus, India, Italy

2

Open banking – revolution or risk?

Banking & Financial Services / Nigeria

3

Aviation industry trends

Aviation / Argentina, Bahamas, Brazil, France, Germany, Israel, Peru